Cytokinetics, Incorporated (CYTK) stock analysis

CYTK · Cytokinetics, Incorporated

Latest recorded price: USD 53.17

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -2.4%, free cash flow margin -607.5%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare